Abstract
Proteasome and HDAC inhibitors interact strongly to promote cell death in multiple myeloma and other human cancer cells. This study challenges current assumptions about the mechanisms underlying these interactions.
Original language | English (US) |
---|---|
Pages (from-to) | 308-309 |
Number of pages | 2 |
Journal | Blood |
Volume | 116 |
Issue number | 3 |
DOIs |
|
State | Published - Jul 22 2010 |
Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology